We have a great respect for nature. By using deep technology to amplify its gifts we are creating a disruptive multi cancer early detection test.
Spotitearly is currently conducting a large clinical trial for screening breast, lung, colon and prostate cancers in one test. During training phase, our test showed higher sensitivity and better specificity in detecting early stages of cancer compared to any existing test on the market today. Stay tuned.
We, a group of passionate multidisciplinary experts with a century of experience between us in AI, biology, medicine, zoology, business and operations, came together to accomplish this (ultra) important mission.